A US Food and Drug Administration (FDA) official acknowledged significant regulatory hurdles in the development of products ...
If the FDA approves a drug for a neglected tropical disease, the company gets a voucher that accelerates review of another drug. This remains controversial.
FDA moves shaping drug development and oversight include new gene therapy guidance, clinical trial transparency efforts, and recent drug approvals.
The US Food and Drug Administration (FDA) has called on its Pharmacy Compounding Advisory Committee to discuss whether a ...
By Sneha S K April 16 (Reuters) - The U.S. Food and Drug Administration should be more transparent when granting accelerated ...
By Kamal Choudhury and Sneha S K April 15 (Reuters) - The U.S. Food and Drug Administration will convene a panel of outside ...
The FDA will convene an expert advisory panel in July 2026 to evaluate whether certain peptides should become more widely ...
Kim Trautman, an industry expert, shares some practical tips and tools for companies to navigate FDA’s new inspection process ...
On Wednesday, the Food and Drug Administration (FDA) said it plans to hold a meeting in July to review whether to loosen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results